Glucose, Viaflo Baxter (Glucose)

Glucose, Viaflo Baxter is employed in various medical contexts where rapid carbohydrate delivery is required. It is commonly used:

• To treat or prevent low blood sugar (hypoglycaemia) in patients unable to take oral glucose.
• As an energy source during surgery or intensive care when patients cannot eat.
• To replenish fluid and electrolyte balance in patients receiving parenteral nutrition.
• In diagnostic procedures such as glucose tolerance testing when administered intravenously.
• As a carrier for certain intravenous medications to maintain osmolarity.

Glucose, Viaflo Baxter may cause a range of reactions, most of which are related to the infusion process or the sugar content.

Common

• Mild hyperglycaemia (temporary rise in blood glucose levels).
• Local irritation at the infusion site, such as redness or swelling.
• Nausea or mild gastrointestinal discomfort.
• Headache or dizziness during rapid infusion.
• Fluid overload signs, such as mild edema.

Serious

• Severe hyperglycaemia leading to ketoacidosis in susceptible individuals.
• Allergic reaction including rash, itching, or anaphylaxis.
• Electrolyte imbalance, particularly hyponatraemia.
• Venous thrombosis at the catheter site.
• Acute renal impairment in patients with pre‑existing kidney disease.

When using Glucose, Viaflo Baxter, healthcare professionals should consider several safety measures. Important precautions include:

• Assessing the patient’s blood glucose level before and during infusion.
• Adjusting infusion rate in patients with diabetes or impaired glucose tolerance.
• Monitoring fluid balance to avoid overload, especially in heart failure or renal insufficiency.
• Using aseptic technique to prevent catheter‑related infections.
• Checking for contraindications such as known hypersensitivity to glucose solutions.
• Evaluating electrolyte status, particularly sodium and potassium levels, before administration.

Glucose, Viaflo Baxter can interact with other medications or conditions, influencing its safety and effectiveness.

Avoid

• Co‑administration with high‑dose insulin without close glucose monitoring.
• Simultaneous infusion of hypertonic solutions that may exacerbate hyperglycaemia.
• Use in patients with severe hyperosmolar states without correction.

Use with caution

• Concurrent use of diuretics that may affect fluid and electrolyte balance.
• Administration alongside catecholamines or glucocorticoids that raise blood glucose.
• Patients receiving total parenteral nutrition, requiring careful carbohydrate calculation.